Half of all patients are fighting a rare cancer.
About 50 percent of people with cancer have a rare cancer. Rare cancers include brain, pancreatic, ovarian, stomach, all types of pediatric cancers, and many others. Even though they account for about half of all cancer diagnoses when combined, research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality. MSK’s close collaboration between doctors and researchers is a unique strength: new drugs and therapies developed in the lab can be moved quickly to patients’ bedsides.
An estimated 1,685,210 new cancer cases will be diagnosed in 2016.
Approximately 50% of people with cancer are battling a rare cancer.
Rare cancers include brain, pancreatic, ovarian, thyroid, and stomach cancers; leukemia and lymphoma; all pediatric cancers; and many others.
Each year MSK treats more than 400 subtypes of cancer.